Inflammatory bowel diseases (IBDs) develop as a result of complex interactions among
genes, innate immunity and environmental factors, which are related to the gut microbiota …

Akkermansia muciniphila is a commensal bacterium of the gut mucus layer. Although both in
vitro and in vivo data have shown that A. muciniphila strains exhibit strain-specific …

Inflammatory bowel disease (IBD) is associated with the microbial composition of the gut
and its metabolites. Akkermansia muciniphila is a probiotic that exerts a significant …

Akkermansia muciniphila has been proved to play a crucial role in the progression of colitis,
but its underlying mechanism remains inconclusive. In this study, we aim to investigate the …

Akkermansia muciniphila (A. muciniphila) plays an important role in intestinal regulation,
while it is presently unclear whether live or pasteurized A. muciniphila has different effects …

Akkermansia muciniphila is potential probiotic in that its type strain ATCC BAA-835 has
beneficial effects upon obesity and diabetes. However, whether A. muciniphila can improve …

The present study aimed to determine if metformin exerts anti-inflammatory and mucus-
protective effects via the gut microbiota. Metformin has extensive benefits including anti …

Gut microbial preparations are widely used in treating intestinal diseases but show mixed
success. In this study, we found that the therapeutic efficacy of A. muciniphila for dextran …

Akkermansia muciniphila is a Gram-negative anaerobic mucus-layer-degrading bacterium
that colonizes the intestinal mucosa of humans and rodents. Metagenomic data have shown …

Colorectal cancer (CRC) is one of the most common digestive tract malignancies and
inflammation and gut microbiota are well-known key factors to influence CRC development …